Collected Resources for Chemists on the COVID-19 Coronavirus from ACS Publications

Jesse Stanchak 4 months ago

The global crisis surrounding the novel coronavirus 2019–nCoV, commonly known as the COVID-19 coronavirus, is at the forefront of everyone’s mind. It has affected the lives and the work of people around the world, including chemists. Yet chemists are also at the forefront of the fight to understand, contain, treat, and eventually defeat the disease. The American Chemical Society takes this threat seriously and remains committed to supporting chemists during this difficult time as part of its mission to advance the broader chemistry enterprise around the world. Below is a collection of news, research, and resources for chemists related to the COVID-19 coronavirus pandemic, courtesy of ACS Publications.

Please bookmark this page and share it with your professional network, as it will be updated with new information and chemistry resources related to the pandemic as they become available.

Frequently Asked Questions

Click below to read answers to common questions about ACS Publications’ operations during the COVID-19 crisis.

ACS Publications Response to the Pandemic

What is ACS doing to ensure that coronavirus related research is available?

ACS has made all coronavirus-related research published in our 60+ portfolio of journals open access and free-to-read since learning of the novel coronavirus outbreak. The most effective way to access this research is through this virtual issue, which is being updated regularly as new articles are published. Additionally, ACS has made all COVID-19 related research published in ACS journals freely and immediately available in the National Institutes of Health PubMed and World Health Organization (WHO) databases.

How is ACS supporting the federal and global COVID-19 response?

As the world’s largest scientific society, ACS is doing everything possible to aid in the global and federal response to the pandemic. Information about ACS efforts in this area is available on the ACS resources webpage. In addition to enabling free access to all coronavirus-related research, CAS, a division of the American Chemical Society, is reaching out to offer its considerable expertise to organizations investing their efforts toward vaccine and therapeutic research as they evaluate the means to combat COVID-19. This assistance, offered at no charge, might involve helping researchers get needed answers or analyses quickly, providing access to CAS solutions, satisfying requests for custom-curated data sets relevant to a target of interest or collaborating with our CAS scientists on a challenging formulations problem, among others. You can contact CAS at the CAS Customer Center.

Does ACS have any resources for families teaching children or young adults about science and chemistry at home?

ACS has made resources available to help in teaching high school, middle school, and elementary school students. The American Association of Chemistry Teachers has also unlocked resources for families learning from home. Additional educational resources can be found on ACS’ Educate resource page.

I’m a professor teaching remotely. Are there any resources I can review?

ACS’s member magazine, Chemical & Engineering News (C&EN) has compiled useful tips for teaching online. The Journal of Chemical Education has also created an open-access, free-to-read collection of articles on this topic. Additional resources can be found on the ACS Educate resource page.

Does ACS have any materials for non-chemists who would like to learn more about the pandemic and how it affects our lives?

C&EN has made all of its coverage of the coronavirus pandemic open access and free-to-read for all. C&EN’s reporting includes coverage of the scientific advances in fighting the virus and news about the impact of the pandemic on universities, labs, and industry.

To learn more about the chemistry behind coronavirus, how vaccines are made, and how materials like soap and hand sanitizer work to fight the virus, visit, and subscribe to ACS’s Reactions YouTube channel. Additional materials can be found on ACS’ Communicate resource page.

Publishing and Journal Activity

Will there be delays in the publication of my article during the pandemic?

At the moment, we are not experiencing any delays in the publication process, but individual circumstances may lead to delays in peer review. If you have questions about the timeline for publication of an article, contact your journal’s editorial office.

What should I do if I need additional time to submit revisions to an article?

If you need more time, contact your journal’s editorial office and explain your request. We’ve communicated the need to be flexible during this unprecedented time to all ACS editors, who understand that authors may be under challenging circumstances.

Will the release of any ACS journals be delayed?

We are doing everything we can to minimize any journal disruptions, and at this time, we expect no delay in the release of any ACS journal articles or issues. If this should change, we will communicate updates to our subscribers and authors.

How can I submit my research quickly?

Uploading your research to ChemRxiv is the fastest way to make your work public. ChemRxiv is a free-to-use service for disseminating unpublished preprints in chemistry and related areas. Preprints are easily searchable and free to read, many with licenses that permit reuse. Uploading your manuscript to ChemRxiv prior to submitting it to a journal for peer review is the quickest way to document your research and make it available to the chemistry community. Please note that while ChemRxiv carries out checks for problematic content, the curators there do not carry out peer review.

As many universities and labs have closed, what considerations should I make when performing a peer review?

We’ve asked our peer reviewers and editors to refrain from requesting additional experiments except when absolutely necessary, as doing so during this time may delay publication. Our journal editorial offices are aware of the difficulties that researchers face when additional lab work is requested; they are carefully evaluating all requests for any additional experimentation from peer reviewers at this time.

I am able to peer review. How can I let editors know of my availability?

We encourage you to accept invitations to peer review, and/or contact journal editorial offices in your field and let them know of your availability. Our peer reviewers are vital to the publication process, so if you find yourself with time, ACS journal editors will no doubt appreciate your expertise.

I thought I had time to review an article, but my circumstances have changed. What should I do?

We understand that individual circumstances are changing on a daily basis. We appreciate your commitment to peer review, but if you are unable to complete a review, please contact the journal editorial office and explain that you are no longer available. You will still be contacted for peer review requests in the future unless you wish otherwise.

Remote Access to ACS Publications

My university is closed. How can I access ACS Publications without using my university’s VPN?

ACS Publications has a variety of options for how you can access articles remotely. Visit our remote access resource page to learn about options for you and for your institution.

I still have access to my university network but plan to begin working and/or studying remotely soon. How can I maintain access to ACS Publications when not on their network?

You can pair a device while on your university network and maintain access to ACS Publications while working remotely. To pair your device, follow the instructions here.

ACS has enabled “federated authentication” for my university. What is federated authentication?

Federated authentication is a method for allowing members of one organization to use their authentication credentials to access a web application of another organization. This means that students or researchers working off-campus can use their campus credentials to access ACS Publications content without the need for a VPN.

Is Patrons’ privacy protected when logging in with federated authentication?

Institutions are in control over the information that is released about their users. ACS Publications does not require any personally identifiable information (e.g. name or email address). In addition, as a division of the American Chemical Society, we are governed by the Society’s overarching privacy policy, available here.

Will IP authentication and COUNTER reports be affected?

No, enabling remote access via federated authentication does not impact the use of IP address authentication for any users directly connected to the campus network or remotely connected via a VPN/proxy server. In addition, enabling remote access via federated authentication will have no impact on COUNTER reports. COUNTER reports will include usage while on-campus, off-campus, and connected via a VPN/proxy server, or off-campus using federated authentication.

Federated authentication is not yet available through my university. Can my school be added?

The list of institutions that have had federated authentication enabled is growing rapidly. See a full list and search for your school. We are continuing to add new universities every day, so please check back regularly if you don’t see your institution yet.

Get Access to COVID-19 Coronavirus Research from ACS Publications

Chemistry in Coronavirus Research: A Free-to-Read Collection from the American Chemical Society
***
Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
***
Overview of Research on the Fate and Behavior of Enveloped Viruses in the Environment
***
A Collection of COVID-19 Research on ChemRxiv
***
Resources for Teaching Your Chemistry Class Online

Remote Access for Researchers

While you are working and studying remotely, ACS has made it easier for you to access our content. Student and faculty researchers around the world can now sign in without a VPN for a secure connection to ACS Publications content through our partnership with SeamlessAccess, a federated authentication system. For those who still have access to their university networks, you can pair your laptop, tablet, and smartphone to maintain access to ACS research from home. We are adding new remote access options regularly and will continue to ensure that you can access the research you need.

Visit our remote access resource page to learn more and to get instructions on SeamlessAccess and device pairing. If you need additional help or guidance, please email us at acs_pubs_assist@acs.org.

ACS Publications Call for Papers for COVID-19 & Related Research Topics

ACS Publications is committed to rapidly communicating urgent developments in characterizing, preventing, and treating the novel coronavirus (2019-nCoV) or the disease it causes, COVID-19. As part of that commitment, we’re working to assist anyone whose research relates to COVID-19 to publish and share their results as quickly as possible.

We invite you to submit your COVID-19 or coronavirus-related manuscript to one of our journals.

Consideration for COVID-19 Manuscripts & Published Articles

Due to the unique nature of the current situation, ACS Publications has some special measures in place for handling manuscripts and published articles related to COVID-19/coronavirus:

For a limited time, free editing services are available for all manuscripts related to COVID-19/coronavirus. Visit ACS Authoring Services to learn more.
COVID-19/coronavirus-related articles included in the Chemistry in Coronavirus Research Virtual Issue are free to read through the end of 2020.
ACS Publications is sharing all articles related to COVID-19/coronavirus with the World Health Organization (WHO) immediately upon publication, for inclusion in the WHO COVID-19 research database.

Use a Preprint to Share Your Results Even Faster

ACS also welcomes submissions to the preprint server ChemRxiv.

When you post a draft of your manuscript on ChemRxiv, you can share your results with the community and get feedback ahead of formal peer review and publication. You can also use ChemRxiv’s Direct Journal Transfer feature to submit a posted preprint to an established journal for editorial consideration and peer review.

All ACS journals accept manuscripts that have been previously published on ChemRxiv.

Special Issue Calls for Papers

Specific ACS Publications journals are inviting manuscript submissions for Special Issues:

A Message for Authors and Reviewers

For Authors

During these unprecedented times, ACS remains fully committed to supporting our authors. In particular, we want to remain flexible with deadlines for revisions and other requests. Please let your journal’s editorial office know if you need additional time to work on a manuscript revision or run into any other challenges with preparing your manuscript. We are happy to work with you!

To support the publication of your research, ACS staff and Editors are working carefully to ensure that journal operations continue with as little disruption as possible. However, given the challenges presented by the COVID-19 outbreak, you may experience delays in the event that reviewers or editors need more time to complete evaluations of your manuscript. We appreciate your understanding that others involved in the publishing process are experiencing many of the same challenges. Posting a preprint of your research on ChemRxiv is one way to help your work reach its audience as rapidly as possible.

For Reviewers

The current global crisis proves that now more than ever, the contributions of scientists are vital. We appreciate the efforts of our reviewers, as their work allows critical research to continue to be published. However, we completely understand that taking the time to review a manuscript is not always possible, especially at this time. If you receive a review invitation, consider the timeline requested and feel free to decline if it isn’t feasible for you. If you’ve accepted an invitation to review and your situation no longer allows you the time necessary to do so, please contact the journal office as soon as possible and explain that you are no longer able to review. We would encourage you to help the editor by recommending an alternate reviewer whenever possible.

If you decline an invitation to review, our editors will contact you again for future review opportunities unless you indicate that you are not interested. Declining a review during this time does not mean that you will be excluded from future review opportunities.

For others, you may find that you have some additional time available at the moment. In these cases, please accept invitations to review, and let journal offices in your area of expertise know if you are available for more review assignments. Hard-working editors will appreciate knowing you are willing and able to provide your expert feedback!

Finally, given that many researchers are not able to visit their labs during this time, please carefully consider any request for additional experimentation as doing so can further delay publications. We ask that you only recommend experiments if they are essential for publication, and clearly differentiate for the editor between required additions (e.g., critical controls) and suggestions that would strengthen the work but should not stand in the way of publication.

Share Your Posters and Presentations Online

Learn about SciMeetings, a new digital offering from ACS that makes it easy to share scientific posters and presentations online.

Read Ongoing Coverage of the COVID-19 Coronavirus

C&EN has made its coverage of the COVID-19 Coronavirus free.

Watch a Reactions Video about the Chemistry of How Soap Affects Viruses Like COVID-19

News and Updates about the COVID-19 Coronavirus from ACS

Update to Our Reader, Reviewer, and Author Communities—April 2020

ACS Catalysis in the Time of COVID-19

ACS Chemical Biology: Fighting the Coronavirus Outbreak

American Chemical Society terminates its Philadelphia spring national meeting

Frequently asked questions about the meeting closure

Add a Comment

Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

72 Comments

Merid Tessema
4:50 am

I would be too much happy for the information
Miroslav Vrvić
10:00 pm

Also, I would be too satisfied with information!
LIU Peng
1:19 am

Thanks for the valuable informations from ACS.
Huajun Huang
11:56 pm

I have to carefully consider whether to delay my revision or not. Some characterizations in my institution cannot be done.
Jin Schreiner
10:50 am

Than you
Kiumars Bahrami
1:22 pm

Thank you for your attention to this matter!
Shabirqureshi
5:00 am

I think in this situation only practically proved (authentic) papers need to be published and moreover all focus needs to be inclined towards COVID-19 Pandemic drug/Vaccine ,both through conventional and Natural means.. This should be ethically Antiviral but not an Antimalarial drug .
Thanks
- Engr Tunji John Erinle
  Response to Shabirqureshi 9:28 am
  
  It is a good idea research topic to work upon
Ralph Nelson
10:48 pm

How can a retired (60-year) ACS member (no longer an employee of a campus or company or agency) get access to the COVID-19 Resource Center? There seems to be no provision for this on the sign-up page.
- acs.axial
  Response to Ralph Nelson 3:41 pm
  
  The resources linked to on this page are all free to read.
Kalyanashis Jana
3:20 pm

Thanks
Unnat Pandit
8:19 pm

Covid-19 is global crisis, the initiative taken up by ACS to give access to rich scientific content made available on same will be useful to research and embark novel ways of scientific discoveries in managing infectious diseases.
Sougata Sarkar
3:50 pm

A very good initiative from ACS. Due respect and regards….
PEDRO LANA GASTELOIS
11:21 pm

thanks for the opportunity
P.Manikyamba
7:55 am

Thanks for the valuable information
Qusay
5:52 am

It is valuable information, Thanks to ACS
Huarong Nie
2:36 am

Thank you for your attention to this matter!
Yuanjun Yang
10:52 am

Bless！ Any difficulties will pass away soon.
Mohammad Hadi Ghatee
11:40 am

Thank you for your attention to this matter and for linking people together.
jamilu aliyu
1:18 pm

I have satisfied with information you provided
jamilu aliyu
1:55 pm

Thank you for the current research that provides regarding COVID-19 Pandemic drug/Vaccine,and I have too much happy for the information and satisfied as weII,best regards ACS
minakshi prasad
4:15 pm

Hi,
Are there any APC or article submission charges for submission of Coronavirus articles?
Thanks
Minakshi
- acs.axial
  Response to minakshi prasad 5:17 pm
  
  APC policies do not vary based on subject matter. You can read about ACS’ open access policies here: https://acsopenaccess.org/
Jun Yin
7:53 pm

Thanks for the valuable informations from ACS.
hui wang
4:37 am

Thanks
Pranav Shrivastav
9:14 am

This is indeed an invaluable information, the need of the hour. Thank you ACS
Haryanto Ph.D.
2:47 pm

Thanks for this valuable information
Xiaoming
5:01 am

Thank you for your attention to this matter!
Ali GHanadzadeh Gilani
3:09 am

Thank you so much for your valuable information and concern
Fangzhi Huang
12:31 am

Thanks for the valuable informations from ACS
pradeesh narayanan
8:25 pm

thank you management team of ACS
Neelu Chouhan
5:32 pm

Support provided by ACS in this COVID time is highly appreciated
IFEDI EMMANUEL NNAM
1:38 am

Thank you for your attention to this matter
Liang Yan
2:35 am

Thank you for this valuable information from ACS!
Parimal Paul
3:54 am

Thanks for taking initiative for this important research area. The entire world is now looking for a solution for this pandemic diseases.
Vishal Gurumukhi
3:49 am

yes this is global crisis. so I would like to get information. thank you.
Xiaoping Wang
8:46 pm

Thank you for the platform. I hope all over the countries could get through the pandemic and wish our work submitted to ACS could help fight against the crisis.
Guojun Zha
2:33 am

Thank you for your attention！
S.K. Shukla
12:48 am

Many many thanks for information
Viktoria
8:49 am

Thank You for your kindness
Jianguo Sun
8:16 am

A very good initiative from ACS. thanks！support！！
Antonio Aguilar
2:30 pm

Thank you for this initiative
Chhanda Charan Danta
7:42 am

Many Thanks, ACS for this good effort.
Gordon Cragg
9:45 am

Thanks to ACS for this valuable service to the world chemistry community!
William R Kem
11:50 am

Thanks much!
Sanjeev Reddy
10:39 pm

Good initiative towards the current crisis facing all individuals across the globe.
Liu Cao
10:17 pm

Thanks. hope that the epidemic will soon end.
Maoshen Chen
2:32 am

Thank you
Haitao
9:56 pm

Thanks for the valuable resources.
Fernando C. Oliveira
3:13 pm

Thank you for this valuable information from ACS.
Bing Yan
11:49 am

Thanks for your useful information from ACS.
Ajaya Bhattarai
7:40 pm

good ideas to update the news about COVID-19.
Dharma Khanal
11:24 am

Very informative the latest research about COVID 19
Fabio Aricò
8:41 am

thank you for the information.
Dr RAJENDRA PRASAD VASANTA
5:02 am

A very good initiative from American Chemical Society, Due respect & regards and Thank you for your attention in this Issue.
Amy Deveau
6:38 pm

Thank you for the valuable information.
Best,
A. Deveau
Veronique Lee
7:07 pm

Thank you!
Wenju Xu
10:06 am

Thanks for the precious information from ACS.
ashrafsadat ghasemi
3:44 pm

Thank you
Francisco Barrantes
1:43 pm

Our review: “While we wait for a vaccine: Why not think about available drugs? has appeared in Frontiers in Physiology, section on Clinical and Translational Physiology. Here is the link: https://doi.org/10.3389/fphys.2020.00820
Dipankar Chakravorty
1:55 am

Thank you for your most thoughtful comments and actions
- Dipankar Chakravorty
  Response to Dipankar Chakravorty 1:59 am
  
  Thank you for the most useful information
BY HAN
10:25 pm

Thanks for the valuable informations from ACS.
Guojun Zha
8:07 am

I am glad to know these informations
Guoqin Liu
9:50 am

It is valuable information, Thanks to ACS
Jingming Gong
9:42 pm

Thank you very much for providing the special platform in ACS. Let all of us gather together and contribute our efforts to explore and understand more about the COVID-19 Coronavirus.
HILDA REYNA INES ROLDAN ARMASTHANKS
4:22 pm

THANKS
Vicente
12:19 pm

Great for invaluable information
Luxiang Wang
7:57 am

Thanks for the valuable information.
Deyun Wang
9:18 pm

Thank for the valuable informations from ACS.
H Namazi
12:17 am

Thanks for the valuable informations from ACS
Shubhrat Maheshwari
11:32 am

I am keenly interested to publish review article related to Covid-19 in your publication.

Menu

Menu

Search

Popular Search Terms

Stories

Collected Resources for Chemists on the COVID-19 Coronavirus from ACS Publications

Frequently Asked Questions

ACS Publications Response to the Pandemic

What is ACS doing to ensure that coronavirus related research is available?

How is ACS supporting the federal and global COVID-19 response?

Does ACS have any resources for families teaching children or young adults about science and chemistry at home?

I’m a professor teaching remotely. Are there any resources I can review?

Does ACS have any materials for non-chemists who would like to learn more about the pandemic and how it affects our lives?

Publishing and Journal Activity

Will there be delays in the publication of my article during the pandemic?

What should I do if I need additional time to submit revisions to an article?

Will the release of any ACS journals be delayed?

How can I submit my research quickly?

As many universities and labs have closed, what considerations should I make when performing a peer review?

I am able to peer review. How can I let editors know of my availability?

I thought I had time to review an article, but my circumstances have changed. What should I do?

Remote Access to ACS Publications

My university is closed. How can I access ACS Publications without using my university’s VPN?

I still have access to my university network but plan to begin working and/or studying remotely soon. How can I maintain access to ACS Publications when not on their network?

ACS has enabled “federated authentication” for my university. What is federated authentication?

Is Patrons’ privacy protected when logging in with federated authentication?

Will IP authentication and COUNTER reports be affected?

Federated authentication is not yet available through my university. Can my school be added?

Get Access to COVID-19 Coronavirus Research from ACS Publications

Remote Access for Researchers

ACS Publications Call for Papers for COVID-19 & Related Research Topics

Consideration for COVID-19 Manuscripts & Published Articles

Use a Preprint to Share Your Results Even Faster

Special Issue Calls for Papers

Environmental Science & Technology

Journal of Chemical Education

Journal of Proteome Research

A Message for Authors and Reviewers

For Authors

For Reviewers

Share Your Posters and Presentations Online

Read Ongoing Coverage of the COVID-19 Coronavirus

Watch a Reactions Video about the Chemistry of How Soap Affects Viruses Like COVID-19

News and Updates about the COVID-19 Coronavirus from ACS

Categories

Tags

Add a Comment

Cancel reply

72 Comments

Merid Tessema

Miroslav Vrvić

LIU Peng

Huajun Huang

Jin Schreiner

Kiumars Bahrami

Shabirqureshi

Engr Tunji John Erinle

Ralph Nelson

acs.axial

Kalyanashis Jana

Unnat Pandit

Sougata Sarkar

PEDRO LANA GASTELOIS

P.Manikyamba

Qusay

Huarong Nie

Yuanjun Yang

Mohammad Hadi Ghatee

jamilu aliyu

jamilu aliyu

minakshi prasad

acs.axial

Jun Yin

hui wang

Pranav Shrivastav

Haryanto Ph.D.

Xiaoming

Ali GHanadzadeh Gilani

Fangzhi Huang

pradeesh narayanan